Cargando…

High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro

BACKGROUND: Oral contraceptive (OC) use increases venous thromboembolism risk 2-5-fold. Procoagulant changes can be detected in plasma from OC users even without thrombosis, but cellular mechanisms that provoke thrombosis have not been identified. Endothelial cell (EC) dysfunction is thought to init...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouck, Emma G., Arvanitis, Marios, Osburn, William O., Sang, Yaqiu, Reventun, Paula, Ahmadzia, Homa K., Smith, Nicholas L., Lowenstein, Charles J., Wolberg, Alisa S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115293/ https://www.ncbi.nlm.nih.gov/pubmed/37075041 http://dx.doi.org/10.1371/journal.pone.0284333

Ejemplares similares

The transcriptional landscape of human liver endothelial cells
por: Toledano-Sanz, Pablo, et al.
Publicado: (2023)

Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
por: Bouck, Emma G., et al.
Publicado: (2023)

Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in procoagulant samples
por: Chang, William C., et al.
Publicado: (2021)

Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells
por: Patsouras, Markos, et al.
Publicado: (2023)

Self-regulation of procoagulant events on the endothelial cell surface
Publicado: (1985)

Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?
por: Kraja, Aldi T, et al.
Publicado: (2007)

Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value
por: Reynés, Gaspar, et al.
Publicado: (2013)

TMEM16E regulates endothelial cell procoagulant activity and thrombosis
por: Schmaier, Alec A., et al.
Publicado: (2023)

Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions
por: Liu, Xin, et al.
Publicado: (2012)

Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
por: Ji, Shuting, et al.
Publicado: (2019)

Comparison of the coagulopathies associated with COVID‐19 and sepsis
por: Campbell, Robert A., et al.
Publicado: (2021)

Hormonal Contraception
por: Speroff, Leon
Publicado: (1973)

Hormonal Contraception
por: Kase, Nathan
Publicado: (1970)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Elevated Procoagulant Endothelial and Tissue Factor Expressing Microparticles in Women with Recurrent Pregnancy Loss
por: Patil, Rucha, et al.
Publicado: (2013)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry
por: Holnthoner, Wolfgang, et al.
Publicado: (2017)

Immune suppression is associated with enhanced systemic inflammatory, endothelial and procoagulant responses in critically ill patients
por: Brands, Xanthe, et al.
Publicado: (2022)

Non-Hormonal Contraception
por: Howard, Sarah Anne, et al.
Publicado: (2023)

Procoagulant inhibitory properties of paclitaxel poliglumex
por: Nemunaitis, John, et al.
Publicado: (2010)

Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
por: Kilic, Nevin, et al.
Publicado: (2012)

Impact of Epicatechin on the Procoagulant Activities of Microparticles
por: Sinegre, Thomas, et al.
Publicado: (2020)

Evaluation Procoagulant Activity and Mechanism of Astragalin
por: Li, Changqin, et al.
Publicado: (2020)

Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?
por: Fruzzetti, Franca, et al.
Publicado: (2018)

Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
por: Leucker, Thorsten M., et al.
Publicado: (2021)

The association between body mass index and postpartum hemorrhage after cesarean delivery
por: Whitley, Julia, et al.
Publicado: (2023)

Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity
por: Fernández-Bello, Ihosvany, et al.
Publicado: (2013)

Illustrated review article: A new format for disseminating scientific progress
por: Wolberg, Alisa S., et al.
Publicado: (2018)

Fibrinogen and fibrin: An illustrated review
por: Pieters, Marlien, et al.
Publicado: (2019)

Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
por: Verhoef, Daniël, et al.
Publicado: (2017)

The procoagulant effects of fine particulate matter in vivo
por: Kilinç, Evren, et al.
Publicado: (2011)

Procoagulant activity and thrombelastography in Korean hemorrhagic fever.
por: Lee, M., et al.
Publicado: (1986)

Polyphosphate and omptins: novel bacterial procoagulant agents
por: Yun, Thomas H, et al.
Publicado: (2009)

Structural Requirements for the Procoagulant Activity of Nucleic Acids
por: Gansler, Julia, et al.
Publicado: (2012)

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo
por: Reddy, Emily C., et al.
Publicado: (2020)

Procoagulant platelets: Generation, characteristics, and therapeutic target
por: Chu, Yaxin, et al.
Publicado: (2021)

Procoagulant and Antimicrobial Effects of Chitosan in Wound Healing
por: Wang, Chih-Hsin, et al.
Publicado: (2021)

Recent advances in hormonal contraception
por: Li, HW Raymond, et al.
Publicado: (2010)

Advances in male hormonal contraception
por: Antonietta, Costantino, et al.
Publicado: (2014)

Update on male hormonal contraception
por: Gava, Giulia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o6uaustlhbngdrqi09b1ds9dep